HR Execs on the Move

Formativ Health

www.formativhealth.com

 
Formativ Health is a management services organization that is redefining Practice Management and end-to-end Revenue Cycle through the integration of technology-enabled Patient Access, Revenue Cycle Management, Practice Operations and Advisory Services. At Formativ Health our approach is simple: We seek to understand your strategy and business goals so that we can define solutions tailored to your needs and designed to maximize performance. As the health care industry continues to transform, we partner with providers to successfully improve their financial health, adapt to changing risk-based payment models, increase physician productivity and satisfaction, and enhance the patient experience. Our technology-enabled services are designed to ...
  • Number of Employees: 0-25
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

PACS

Providence Administrative Consulting Services (PACS) provides administrative support services that elevate skilled nursing facilities, empowering and equipping local leadership teams to deliver excellent care and make positive contributions to their co...

Rice Home Medical

Rice Home Medical is a Willmar, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Enpath Medical

Enpath Medical, Inc. is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Burbank HealthCare Foundation

Burbank HealthCare Foundation is a Burbank, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Kolltan

Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.